Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy BRITISH JOURNAL OF HAEMATOLOGY Coutre, S. E., Othus, M., Powell, B., Willman, C. L., Stock, W., Paietta, E., Levitan, D., Wetzler, M., Attar, E. C., Altman, J. K., Gore, S. D., Maher, T., Kopecky, K. J., Tallman, M. S., Larson, R. A., Appelbaum, F. R. 2014; 165 (4): 497-503
View details for DOI 10.1111/bjh.12775
View details for Web of Science ID 000334686500007